20210419-lab meeting 逸安 | 賴亮全實驗室

Index

00:29 1.
index 1
00:00 2.
Introduction
00:13 3.
Breast cancer (BC)
00:05 4.
Subtypes of breast cancer:
00:25 5.
Breast cancer (BC)
00:11 6.
** after 20210427.pptx
00:43 7.
Subtypes of breast cancer:
00:51 8.
Treatments of breast cancer
00:49 9.
Chemotherapy of triple-negative breast cancer
00:57 10.
Long non-coding RNA (lnc RNA)
00:39 11.
Myc
00:15 12.
Aim of this study
00:01 13.
Slide 10
01:04 14.
Identification of lncRNAs differentially expressed in breast cancer
00:00 15.
Slide 10
00:00 16.
Aim of this study
00:00 17.
Myc
00:01 18.
Long non-coding RNA (lnc RNA)
00:04 19.
Chemotherapy of triple-negative breast cancer
00:01 20.
Long non-coding RNA (lnc RNA)
00:00 21.
Myc
00:00 22.
Aim of this study
00:00 23.
Slide 10
01:11 24.
Identification of lncRNAs differentially expressed in breast cancer
00:48 25.
Slide 12
00:01 26.
Slide 13
00:36 27.
Slide 12
00:18 28.
Slide 13
01:22 29.
Slide 14
01:29 30.
Linc00839 knockdown suppressed cell proliferation and increased sensitivity to paclitaxel in vitro.
03:01 31.
Slide 16
00:05 32.
Slide 17
00:02 33.
Slide 16
01:46 34.
Slide 17
02:56 35.
Linc00839 knockdown inhibited tumor proliferation in vivo.
01:00 36.
Myc activates Linc00839 transcription and regulates its expression level.
00:01 37.
Slide 20
00:16 38.
Myc activates Linc00839 transcription and regulates its expression level.
03:42 39.
Slide 20
05:45 40.
Linc00839 regulates Lin28B and Myc mRNA and protein expression.
03:11 41.
Slide 22
00:00 42.
Slide 23
00:49 43.
Slide 22
03:00 44.
Slide 23
01:55 45.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
00:03 46.
Slide 25
01:02 47.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
01:38 48.
Slide 25
02:48 49.
Slide 26
00:00 50.
Slide 27
00:49 51.
Comment
11:26 52.
** after 20210427.pptx
00:22 53.
Slide 17

Notes (0)

Not logged in or insufficient permissions!

Comment

00:29 1.
index 1
00:00 2.
Introduction
00:13 3.
Breast cancer (BC)
00:05 4.
Subtypes of breast cancer:
00:25 5.
Breast cancer (BC)
00:11 6.
** after 20210427.pptx
00:43 7.
Subtypes of breast cancer:
00:51 8.
Treatments of breast cancer
00:49 9.
Chemotherapy of triple-negative breast cancer
00:57 10.
Long non-coding RNA (lnc RNA)
00:39 11.
Myc
00:15 12.
Aim of this study
00:01 13.
Slide 10
01:04 14.
Identification of lncRNAs differentially expressed in breast cancer
00:00 15.
Slide 10
00:00 16.
Aim of this study
00:00 17.
Myc
00:01 18.
Long non-coding RNA (lnc RNA)
00:04 19.
Chemotherapy of triple-negative breast cancer
00:01 20.
Long non-coding RNA (lnc RNA)
00:00 21.
Myc
00:00 22.
Aim of this study
00:00 23.
Slide 10
01:11 24.
Identification of lncRNAs differentially expressed in breast cancer
00:48 25.
Slide 12
00:01 26.
Slide 13
00:36 27.
Slide 12
00:18 28.
Slide 13
01:22 29.
Slide 14
01:29 30.
Linc00839 knockdown suppressed cell proliferation and increased sensitivity to paclitaxel in vitro.
03:01 31.
Slide 16
00:05 32.
Slide 17
00:02 33.
Slide 16
01:46 34.
Slide 17
02:56 35.
Linc00839 knockdown inhibited tumor proliferation in vivo.
01:00 36.
Myc activates Linc00839 transcription and regulates its expression level.
00:01 37.
Slide 20
00:16 38.
Myc activates Linc00839 transcription and regulates its expression level.
03:42 39.
Slide 20
05:45 40.
Linc00839 regulates Lin28B and Myc mRNA and protein expression.
03:11 41.
Slide 22
00:00 42.
Slide 23
00:49 43.
Slide 22
03:00 44.
Slide 23
01:55 45.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
00:03 46.
Slide 25
01:02 47.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
01:38 48.
Slide 25
02:48 49.
Slide 26
00:00 50.
Slide 27
00:49 51.
Comment
11:26 52.
** after 20210427.pptx
00:22 53.
Slide 17

Share
- Embed URL
- QR code

Index
Notes
Comment
Fullscreen

20210419-lab meeting 逸安

Duration: 58:36, Browse: 393, Last Updated: 2021-04-19

Prev Next

00:29 1.
index 1
00:00 2.
Introduction
00:13 3.
Breast cancer (BC)
00:05 4.
Subtypes of breast cancer:
00:25 5.
Breast cancer (BC)
00:11 6.
** after 20210427.pptx
00:43 7.
Subtypes of breast cancer:
00:51 8.
Treatments of breast cancer
00:49 9.
Chemotherapy of triple-negative breast cancer
00:57 10.
Long non-coding RNA (lnc RNA)
00:39 11.
Myc
00:15 12.
Aim of this study
00:01 13.
Slide 10
01:04 14.
Identification of lncRNAs differentially expressed in breast cancer
00:00 15.
Slide 10
00:00 16.
Aim of this study
00:00 17.
Myc
00:01 18.
Long non-coding RNA (lnc RNA)
00:04 19.
Chemotherapy of triple-negative breast cancer
00:01 20.
Long non-coding RNA (lnc RNA)
00:00 21.
Myc
00:00 22.
Aim of this study
00:00 23.
Slide 10
01:11 24.
Identification of lncRNAs differentially expressed in breast cancer
00:48 25.
Slide 12
00:01 26.
Slide 13
00:36 27.
Slide 12
00:18 28.
Slide 13
01:22 29.
Slide 14
01:29 30.
Linc00839 knockdown suppressed cell proliferation and increased sensitivity to paclitaxel in vitro.
03:01 31.
Slide 16
00:05 32.
Slide 17
00:02 33.
Slide 16
01:46 34.
Slide 17
02:56 35.
Linc00839 knockdown inhibited tumor proliferation in vivo.
01:00 36.
Myc activates Linc00839 transcription and regulates its expression level.
00:01 37.
Slide 20
00:16 38.
Myc activates Linc00839 transcription and regulates its expression level.
03:42 39.
Slide 20
05:45 40.
Linc00839 regulates Lin28B and Myc mRNA and protein expression.
03:11 41.
Slide 22
00:00 42.
Slide 23
00:49 43.
Slide 22
03:00 44.
Slide 23
01:55 45.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
00:03 46.
Slide 25
01:02 47.
Linc00839 promotes cell invasion and proliferation via PI3K/AKT Signaling Pathways
01:38 48.
Slide 25
02:48 49.
Slide 26
00:00 50.
Slide 27
00:49 51.
Comment
11:26 52.
** after 20210427.pptx
00:22 53.
Slide 17

Location

Folder name

2021

Author

陳逸安

Branch

賴亮全教授

Created

2021-04-19 10:46:54

Last Updated

2021-04-19 11:47:40

Browse

393

Duration

58:36